Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: A prospective, randomized, double-blind, placebo-controlled, multicenter study
dc.contributor.author | Cingi, Cemal | |
dc.contributor.author | Songu, Murat | |
dc.contributor.author | Ural, Ahmet | |
dc.contributor.author | Yildirim, Muzeyyen | |
dc.contributor.author | Erdogmus, Nagehan | |
dc.contributor.author | Bal, Cengiz | |
dc.date.accessioned | 2024-04-24T17:33:38Z | |
dc.date.available | 2024-04-24T17:33:38Z | |
dc.date.issued | 2010 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | We conducted a prospective, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy of chlorhexidine gluconate/benzydamine HCl mouth spray for reducing pain and improving quality of life in patients with acute viral pharyngitis. Prior to treatment, patients rated the intensity of their pain on a visual analog scale and evaluated their quality of life on the 36-Item Short-Form Health Survey. Patients were then randomized to receive either paracetamol (acetaminophen) plus chlorhexidine/benzydamine or paracetamol plus placebo for 7 days. On days 3 and 7 of treatment, the participants again rated the intensity of their pain, and on day 7, they again rated their quality of life. A total of 164 patients were evaluable at study's end-80 in the chlorhexidine/benzydamine group and 84 in the control group. A comparison of self-evaluations revealed that the active treatment group reported less pain on both day 3 (p < 0.001) and day 7 (p = 0.002). Likewise, the chlorhexidine/benzydamine group reported a significantly better quality of life on day 7 (p < 0.001). Chlorhexidine/benzydamine was well tolerated, and no serious adverse events were observed. | en_US |
dc.identifier.endpage | 549 | en_US |
dc.identifier.issn | 0145-5613 | |
dc.identifier.issn | 1942-7522 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.pmid | 21086279 | |
dc.identifier.scopus | 2-s2.0-78650101094 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 546 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/20784 | |
dc.identifier.volume | 89 | en_US |
dc.identifier.wos | WOS:000284921400009 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Sage Publications Inc | en_US |
dc.relation.ispartof | Ent-Ear Nose & Throat Journal | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keyword] | en_US |
dc.title | Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: A prospective, randomized, double-blind, placebo-controlled, multicenter study | en_US |
dc.title | Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: A prospective, randomized, double-blind, placebo-controlled, multicenter study | |
dc.type | Article | en_US |